F-group (family)
2007.15.1.2 Nuc_deoxyrib_tr
Ligands and drugs
224
Member domains
151
with ligand contacts (≤ 4 Å)
67.4% of members
86
with DrugDomain annotations
38.4% of members
68
with a DrugBank compound
30.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2007.15.1.2 belongs to X-group 2007 Flavodoxin-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 77% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03846 | 5HU | 2'-deoxy-5-(hydroxymethyl)uridine 5'-(dihydrogen phosphate) | 6 |
| DB07205 | 6IA | N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE | 4 |
| DB14636 | TR5 | Triciribine phosphate | 4 |
| DB00173 | ADE | Adenine | 3 |
| DB02168 | BP1 | 6-bromopurine | 3 |
| DB02753 | SNI | Selenoinosine | 3 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 2 |
| DB03403 | C5P | Cytidine-5'-Monophosphate | 2 |
| DB03763 | 5MD | 5-methyl-2'-deoxypseudouridine | 2 |
| DB03800 | UMP | Deoxyuridine monophosphate | 2 |
| DB04580 | 12Q | 1-Methyl-2-quinolone | 2 |
| DB04605 | 5IQ | 5-Aminoisoquinoline | 2 |
| DB02676 | B3P | 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 10 |
| 6C6 | N-cyclopentyladenosine 5'-(dihydrogen phosphate) | 8 |
| 5HU | 5-HYDROXYMETHYLURIDINE-2'-DEOXY-5'-MONOPHOSPHATE | 7 |
| RIB | alpha-D-ribofuranose | 6 |
| 2DR | 2-deoxy-beta-D-erythro-pentofuranose | 4 |
| 6IA | N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE | 4 |
| 6K6 | N-(furan-2-ylmethyl)adenosine 5'-(dihydrogen phosphate) | 4 |
| A1H0F | (2~{R},3~{R})-4,4-bis(fluoranyl)-2-(hydroxymethyl)oxolan-3-ol | 4 |
| A1I1M | 2-[1-methyl-5-[[1-[2-(methylamino)phenyl]carbonylpiperidin-4-yl]amino]-1,2,4-triazol-3-yl]-1~{H}-indole-6-carbonitrile | 4 |
| A1I1U | 8-[3-(6-cyano-1~{H}-indol-2-yl)-5-[[1-[2-(methylamino)phenyl]carbonylpiperidin-4-yl]amino]-1,2,4-triazol-1-yl]octanoic acid | 4 |
| CFB | 2-CHLORO-9-(2-DEOXY-2-FLUORO-B -D-ARABINOFURANOSYL)-9H-PURIN-6-AMINE | 4 |
| DIH | 7-[[(3R,4R)-3-(hydroxymethyl)-4-oxidanyl-pyrrolidin-1-ium-1-yl]methyl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one | 4 |
| N6P | 6-(naphthalen-2-yl)-9-(5-O-phosphono-beta-D-ribofuranosyl)-9H-purine | 4 |
| SRA | ADENOSINE -5'-THIO-MONOPHOSPHATE | 4 |
| TR5 | 5-methyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,8-pentaazaacenaphthylen-3-amine | 4 |
| ZNmetal | ZINC ION | 4 |
| 28Y | 3H-imidazo[2,1-b]purin-4(5H)-one | 3 |
| 3D1 | (2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-tetrahydro-2-(hydroxymethyl)furan-3-ol | 3 |
| ADE | ADENINE | 3 |
| BP1 | 6-BROMO-7H-PURINE | 3 |